Intellectual Property

  • October 08, 2024

    Limp Bizkit's $200M Suit Says UMG Hid Royalties

    Rock band Limp Bizkit hit Universal Music Group Inc. on Tuesday with a suit seeking more than $200 million, alleging that the music company created and used technology that allows it to hide royalties from its artists and hoard profits.

  • October 08, 2024

    3rd Circ. Directs Court To Explain If Natera Ads 'Literally False'

    A Third Circuit panel on Tuesday sent allegations of false advertising against medical test maker Natera back to district court, directing the judge to determine whether a jury had sufficient evidence last year to find that eight of the company's advertisements were "literally false."

  • October 08, 2024

    Ex-Clients Say BakerHostetler Can't Keep Suit In Fed. Court

    Former clients of BakerHostetler strengthened their request to send to Georgia state court a suit alleging the firm mishandled their patent application for a smart wardrobe system, arguing that the case doesn't raise patent law questions and thus shouldn't remain in federal court.

  • October 08, 2024

    Judge Clarifies Licensing Curbs On Paul Newman Foundation

    The foundation established by the actor Paul Newman cannot license his publicity and intellectual property rights to any university or other nonprofit, studio or publisher or any luxury brand for advertising, a Connecticut state court judge has said, responding to a request to clarify a preliminary injunction she issued.

  • October 08, 2024

    Fed. Circ. Restores Debit Card Patent Suit Against Aetna

    The Federal Circuit on Tuesday revived patent litigation targeting Aetna's Visa- and Mastercard-branded debit cards, while holding that certain aspects of dismissal decisions should be reviewed from scratch on appeal.

  • October 08, 2024

    NC Judge Scolds Clinic And Hospital Over Bids To Seal TM Case

    A North Carolina federal judge chastised a weight loss center, a hospital and a community health provider for their bids to seal a large swath of information in a trademark infringement lawsuit, invoking the secretive medieval court that gave rise to the phrase "star chamber."

  • October 08, 2024

    Exporting Chips To China Doesn't Merit 7 Years, 9th Circ. Told

    Counsel for a former UCLA electrical engineering professor urged the Ninth Circuit on Tuesday to reduce his seven-year prison sentence for illegally exporting high-powered semiconductor chips to China, saying the conduct did not amount to an evasion of national security controls.

  • October 08, 2024

    Axinn Rebrands Ahead Of NYC Relocation

    Axinn Veltrop & Harkrider LLP announced Tuesday a new image rebrand in advance of the planned relocation of its New York office to Rockefeller Center at the end of the year.

  • October 07, 2024

    Apple Beats Masimo's Allegations Of Misleading USPTO

    Apple did not deceive the U.S. Patent and Trademark Office when obtaining design patents, a Delaware federal judge ruled Monday, shooting down a key argument from Masimo Corp. as the parties continue to fight over the market for smartwatches.

  • October 07, 2024

    Skiplagged Cost American Airlines $18M, Jury Hears

    American Airlines Inc. claims that airfare search engine Skiplagged Inc. cost it $18 million by masquerading as an authorized agent of the airline, but Skiplagged told a Texas jury Monday that American sued it to limit customers' "freedom of choice."

  • October 07, 2024

    PetSmart Can't Shear Down Dog Food Trademark Suit

    A Kentucky federal judge declined PetSmart's bid to narrow a dog food company's intellectual property lawsuit against the pet products retailer, holding that the case qualifies for an exception that allows courts to intervene in pending matters before the U.S. Patent and Trademark Office.

  • October 07, 2024

    9th Circ. Asked To Take Another Look At 'Patent Misuse' Case

    Atrium Medical Corp. has urged the full Ninth Circuit to reconsider a panel ruling siding with rival medical product maker C.R. Bard in a $52.8 million lawsuit over patent royalty provisions, saying the panel "inappropriately dispensed with the evidence adduced below and the district court's fact-finding."

  • October 07, 2024

    ITC Judge Pushes For Import Ban In Liver Drug Secrets Row

    The U.S. International Trade Commission's chief judge is recommending the agency block a Hong Kong-listed drug developer from potentially marketing unapproved treatments for a type of liver disease for the next seven years, a win for another company behind a different unapproved treatment for the same type of liver disease.

  • October 07, 2024

    Fed. Circ. Questions If Safer OxyContin Profits Came From IP

    An attorney for Purdue Pharma didn't seem to find much purchase at the Federal Circuit on Monday as he argued that the company's patents for abuse-deterrent OxyContin weren't obvious, claiming other companies had ample opportunity to reach a solution and failed to do so.

  • October 07, 2024

    Music Label Says 2 Live Crew Songs Were Works For Hire

    The owner of music label Lil' Joe Records took the stand Monday as he began to make the case that the members of hip-hop group 2 Live Crew were employees, not independent contractors, when they produced their hits and therefore cannot claw back their rights to the recordings.

  • October 07, 2024

    Mylan, Novo Nordisk Settle Ozempic Patent Dispute

    Mylan Pharmaceuticals and Novo Nordisk have asked the Patent Trial and Appeal Board to terminate Mylan's request to review whether a patent covering Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic holds up, telling the board the two sides have resolved their dispute.

  • October 07, 2024

    New Bill Would Enact 'Commonsense' Litigation Disclosures

    A top Republican on the House Judiciary Committee announced Monday he introduced legislation to require the disclosure of parties receiving payments in civil lawsuits, a phenomenon known as "third-party litigation financing," in order to prevent abuses in the legal system.

  • October 07, 2024

    5 Decisions To Know By Outgoing Mass. Chief Judge

    Chief Massachusetts U.S. District Judge F. Dennis Saylor IV, who announced Monday that he will step back from full-time judicial service next summer, has presided over numerous significant cases in recent years, including a dispute over the U.S. Securities and Exchange Commission's disgorgement powers and a birth defects suit against GlaxoSmithKline.

  • October 07, 2024

    Apple Doesn't Infringe Digital Identity Patents, Jury Finds

    A federal jury in Austin, Texas, has rejected a $361 million patent case from a longtime ExxonMobil employee who had targeted in-house cybersecurity hardware used in Apple iPhones.

  • October 07, 2024

    Contractor Passed 20K Accounts To Rivals, Security Co. Says

    A Connecticut home security monitoring company has accused a sales contractor of purchasing a list of 20,000 of its accounts from a service technician and trying to lure a colleague into helping him sell the secret data to competitors, causing an alleged "substantial loss of customers."

  • October 07, 2024

    Judge Backs $3.3M DOD Sole-Source Parts Deal For Boeing

    A Court of Federal Claims judge has denied a protest over a $3.3 million Defense Logistics Agency sole-source contract with Boeing, covering helicopter spare parts the protester argued it could also provide, ruling the DLA reasonably determined Boeing was the only available source.

  • October 07, 2024

    NCAA Wins Preliminary OK For Revised $2.78B NIL Settlement

    A California federal judge on Monday preliminarily approved the NCAA's revised $2.78 billion antitrust settlement with athletes suing over the organization's name, image and likeness compensation rules.

  • October 07, 2024

    Willkie Tech Patent Litigation Chair Joins Covington In DC

    The former chair of Willkie Farr & Gallagher LLP's tech patent litigation group, who has more than two decades of experience litigating computer hardware and software matters for major corporations, has moved his practice to Covington & Burling LLP's Washington, D.C., office, the firm announced Monday.

  • October 07, 2024

    6 High Court Cases To Watch For Trial Attorneys

    As the U.S. Supreme Court lifts the curtain on a new term, the justices are slated to consider a variety of cases impacting the work of trial litigators, including a death penalty case over a state-disavowed conviction, the boundaries of the Racketeer Influenced and Corrupt Organizations Act, and corporate veil piercing.

  • October 07, 2024

    Justices Snub Musician's 'Rockstar' IP Feud With Nickelback

    The U.S. Supreme Court on Monday declined to hear a copyright complaint from a musician who sued Canadian band Nickelback for allegedly ripping off his song to make their hit record "Rockstar."

Expert Analysis

  • Why Jurors Balk At 'I Don't Recall' — And How To Respond

    Author Photo

    Jurors often react negatively to a witness who responds “I don’t remember” because they tend to hold erroneous beliefs about the nature of human memory, but attorneys can adopt a few strategies to mitigate the impact of these biases, say Steve Wood and Ava Hernández at Courtroom Sciences.

  • Beware Of Trademark Scammers Leveraging USPTO Data

    Author Photo

    Amid a recent uptick in fraudulent communications directed at trademark applicants, registrants must understand how to protect themselves and their brand from fraudulent schemes and solicitation, say Michael Kelber and Alexandra Maloney at Neal Gerber.

  • Series

    Fishing Makes Me A Better Lawyer

    Author Photo

    Atop the list of ways fishing makes me a better lawyer is the relief it offers from the chronic stress of a demanding caseload, but it has also improved my listening skills and patience, and has served as an exceptional setting for building earnest relationships, says Steven DeGeorge​​​​​​​ at Robinson Bradshaw.

  • 10 Tips To Build Trust With Your Witness During Trial Prep

    Author Photo

    Preparing a witness for deposition or trial requires more than just legal skills — lawyers must also work to cultivate trust with the witness, using strategies ranging from wearing a hat when conducting mock cross-examination to offering them a ride to court before they testify, say Faye Paul Teller and Sara McDermott at Munger Tolles.

  • A Healthier Legal Industry Starts With Emotional Intelligence

    Author Photo

    The legal profession has long been plagued by high rates of mental health issues, in part due to attorneys’ early training and broader societal stereotypes — but developing one’s emotional intelligence is one way to foster positive change, collectively and individually, says attorney Esperanza Franco.

  • PTAB Rulings Shed Light On Quantum Computing Patents

    Author Photo

    Recent Patent Trial and Appeal Board decisions on enablement rejections against quantum computing patent claims provide patent practitioners with valuable guidance on best practices for avoiding and overcoming enablement, say Fred Qiu and Alex Nie at Sheppard Mullin.

  • To Make Your Legal Writing Clear, Emulate A Master Chef

    Author Photo

    To deliver clear and effective written advocacy, lawyers should follow the model of a fine dining chef — seasoning a foundation of pure facts with punchy descriptors, spicing it up with analogies, refining the recipe and trimming the fat — thus catering to a sophisticated audience of decision-makers, says Reuben Guttman at Guttman Buschner.

  • Circuit Judge Writes An Opinion, AI Helps: What Now?

    Author Photo

    Last week's Eleventh Circuit opinion in Snell v. United Specialty Insurance, notable for a concurrence outlining the use of artificial intelligence to evaluate a term's common meaning, is hopefully the first step toward developing a coherent basis for the judiciary's generative AI use, says David Zaslowsky at Baker McKenzie.

  • Fed. Circ. Rulings Crystallize Polymorph Patent 'Obviousness'

    Author Photo

    A comparison of two recent Federal Circuit obviousness challenge decisions regarding polymorph patents provides helpful insight into the assessment of screening arguments, particularly the issue of reasonable expectation of success, say Michael Green and John Molenda at Steptoe.

  • 3 Infringement Defenses To Consider 10 Years Post-Nautilus

    Author Photo

    In the 10 years since the U.S. Supreme Court’s influential Nautilus ruling, the spirit of the “amenable to construction” test that the opinion rejected persists with many patent litigators and judges, so patent infringement defense counsel should always consider several key arguments, says John Vandenberg at Klarquist Sparkman.

  • Attys Beware 2 Commonly Overlooked NIL Contract Issues

    Author Photo

    As name, image and likeness deals dominate high school and collegiate sports, preserving a client's NCAA eligibility should be a top priority, so lawyers should understand the potentially damaging contract provisions they may encounter when reviewing an agreement, says Paula Nagarajan at Arnall Golden.

  • FTC Focus: Exploring The Meaning Of Orange Book Letters

    Author Photo

    The Federal Trade Commission recently announced an expansion of its campaign to promote competition by targeting pharmaceutical manufacturers' improper Orange Book patent listings, but there is a question of whether and how this helps generic entrants, say Colin Kass and David Munkittrick at Proskauer.

  • Trending At The PTAB: Real Party In Interest And IPR

    Author Photo

    The Patent Trial and Appeal Board’s recent Luminex v. Signify decision, finding a complaint seeking indemnification may be treated as a public demand sufficient to establish a real party-in-interest, shows that the board continues to apply a broad and expansive definition to that term, say Yicong (Eve) Du and Yieyie Yang at Finnegan.

  • Investors Can Aid In The Acceptance Of Psychedelic Medicine

    Author Photo

    Psychedelic medicine is ready to have its breakthrough moment, and although it still faces political, legal and communications challenges, private equity investors can play a significant role in changing the public perception on psychedelics from taboo to acceptance, say Kimberly Chew at Husch Blackwell, Charlie Panfil at the Daschle Group and Ethan Lutz at FTI Consulting.

  • 12 Keys To Successful Post-Trial Juror Interviews

    Author Photo

    Post-trial interviews offer attorneys an avenue to gain valuable insights into juror decision making and get feedback that can inform future litigation strategies, but certain best practices must be followed to get the most out of this research tool, say Alexa Hiley and Brianna Smith at IMS Legal.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!